CASP3 and cancer: Previously, it is reported that decitabine can enhance caspase-3 cleavage to GSDME and cause cancer cell pyroptosis, indicating that targeting pyroptosis might be a promising therapeutic strategy for cancer (Zhao et al., 2020).